Vinué Laura, Corcoran Marian A, Hooper David C, Jacoby George A
Lahey Hospital and Medical Center, Burlington, Massachusetts, USA Massachusetts General Hospital, Boston, Massachusetts, USA.
Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
Antimicrob Agents Chemother. 2015 Dec 28;60(3):1537-45. doi: 10.1128/AAC.02167-15.
Plasmid-mediated qnr genes provide only a modest decrease in quinolone susceptibility but facilitate the selection of higher-level resistance. In Escherichia coli strain J53 without qnr, ciprofloxacin resistance often involves mutations in the GyrA subunit of DNA gyrase. Mutations in gyrA were absent, however, when 43 mutants with decreased ciprofloxacin susceptibility were selected from J53(pMG252) with qnrA1. Instead, in 13 mutants, individual and whole-genome sequencing identified mutations in marR and soxR associated with increased expression of marA and soxS and, through them, increased expression of the AcrAB pump, which effluxes quinolones. Nine mutants had increased expression of the MdtE efflux pump, and six demonstrated increased expression of the ydhE pump gene. Many efflux mutants also had increased resistance to novobiocin, another pump substrate, but other mutants were novobiocin hypersusceptible. Mutations in rfaD and rfaE in the pathway for inner core lipopolysaccharide (LPS) biosynthesis were identified in five such strains. Many of the pump and LPS mutants had decreased expression of OmpF, the major porin channel for ciprofloxacin entry. Three mutants had increased expression of qnrA that persisted when pMG252 from these strains was outcrossed. gyrA mutations were also rare when mutants with decreased ciprofloxacin susceptibility were selected from E. coli J53 with aac(6')-Ib-cr or qepA. We suggest that multiple genes conferring low-level resistance contribute to enhanced ciprofloxacin resistance selected from an E. coli strain carrying qnrA1, aac(6')-Ib-cr, or qepA because these determinants decrease the effective ciprofloxacin concentration and allow more common but lower-resistance mutations than those in gyrA to predominate.
质粒介导的qnr基因仅适度降低喹诺酮敏感性,但有助于选择更高水平的耐药性。在不含qnr的大肠杆菌J53菌株中,环丙沙星耐药性通常涉及DNA促旋酶GyrA亚基的突变。然而,当从携带qnrA1的J53(pMG252)中选出43株环丙沙星敏感性降低的突变体时,未发现gyrA突变。相反,在13个突变体中,个体和全基因组测序鉴定出marR和soxR中的突变,这些突变与marA和soxS的表达增加相关,并通过它们增加了AcrAB泵的表达,该泵可外排喹诺酮。9个突变体中MdtE外排泵的表达增加,6个突变体中ydhE泵基因的表达增加。许多外排突变体对另一种泵底物新生霉素的耐药性也增加,但其他突变体对新生霉素高度敏感。在5株这样的菌株中鉴定出了内核脂多糖(LPS)生物合成途径中rfaD和rfaE的突变。许多泵和LPS突变体中,环丙沙星进入的主要孔蛋白通道OmpF的表达降低。当从这些菌株中去除pMG252时,有3个突变体中qnrA的表达仍然增加。当从携带aac(6')-Ib-cr或qepA的大肠杆菌J53中选出环丙沙星敏感性降低的突变体时,gyrA突变也很少见。我们认为,赋予低水平耐药性的多个基因有助于从携带qnrA1、aac(6')-Ib-cr或qepA的大肠杆菌菌株中选择增强的环丙沙星耐药性,因为这些决定因素降低了有效的环丙沙星浓度,并使比gyrA中更常见但耐药性更低的突变占主导地位。